Suppr超能文献

影响盆腔脏器清扫术后住院时间的因素。

Factors affecting hospital length of stay following pelvic exenteration surgery.

作者信息

Guo Ying, Chang Eugene, Bozkurt Mehtap, Park Minjeong, Liu Diane, Fu Jack B

机构信息

Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Department of Medicine, Division of Physical Medicine and Rehabilitation, Toronto Rehabilitation Institute, Toronto, Canada.

出版信息

J Surg Oncol. 2018 Mar;117(3):529-534. doi: 10.1002/jso.24878. Epub 2017 Oct 16.

Abstract

BACKGROUND AND OBJECTIVES

Total pelvic exenteration are performed in patients with locally advanced or recurrent pelvic malignances. Many patients have prolong hospital length of stay (LOS), but risk factors are not clearly identified.

METHODS

From 2002 through 2012, 100 consecutive patients undergoing pelvic exenteration were retrospectively reviewed. A general linear model was used to examine risk factors for prolonged hospital LOS.

RESULTS

Among the 100 patients, 51 had gastrointestinal cancer, 14 had genitourinary cancer, 31 had gynecologic cancer, and 4 had sarcoma. Perioperative complications included infection (n = 44), anastomotic leak/fistula (n = 6), wound or flap dehiscence (n = 11), and ileus or bowel obstruction (n = 30). The median (Interquartile range (IQR)) hospital LOS was 15 days (10-21.5 days). On multivariate regression analysis, hospital LOS was significantly prolonged by underweight status, genitourinary cancer or sarcoma diagnosis, ≥2 infections, anastomotic leak/fistula, requiring rehabilitation consult and admission, and ≥2 consultations (P = 0.05).

CONCLUSION

In patients undergoing pelvic exenteration, prolonged hospital LOS is associated with underweight status, genitourinary cancer or sarcoma diagnosis, more than one infection, anastomotic leak/fistula, requiring rehabilitation consult and admission, and more than one consultation. Further study is needed to assess whether minimizing these risk factors can improve hospital LOS in these patients.

摘要

背景与目的

全盆腔脏器切除术用于治疗局部晚期或复发性盆腔恶性肿瘤患者。许多患者住院时间延长,但风险因素尚不明确。

方法

回顾性分析2002年至2012年连续接受盆腔脏器切除术的100例患者。采用一般线性模型检查住院时间延长的风险因素。

结果

100例患者中,51例患有胃肠道癌,14例患有泌尿生殖系统癌,31例患有妇科癌,4例患有肉瘤。围手术期并发症包括感染(n = 44)、吻合口漏/瘘(n = 6)、伤口或皮瓣裂开(n = 11)以及肠梗阻(n = 30)。中位(四分位间距(IQR))住院时间为15天(10 - 21.5天)。多因素回归分析显示,体重过轻、泌尿生殖系统癌或肉瘤诊断、≥2次感染、吻合口漏/瘘、需要康复咨询及住院以及≥2次咨询会显著延长住院时间(P = 0.05)。

结论

在接受盆腔脏器切除术的患者中,住院时间延长与体重过轻、泌尿生殖系统癌或肉瘤诊断、不止一次感染、吻合口漏/瘘、需要康复咨询及住院以及不止一次咨询有关。需要进一步研究以评估降低这些风险因素是否能改善这些患者的住院时间。

相似文献

1
Factors affecting hospital length of stay following pelvic exenteration surgery.
J Surg Oncol. 2018 Mar;117(3):529-534. doi: 10.1002/jso.24878. Epub 2017 Oct 16.
2
Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
Eur J Surg Oncol. 2012 Apr;38(4):361-6. doi: 10.1016/j.ejso.2011.12.002. Epub 2012 Jan 21.
5
Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Gynecol Oncol. 2019 May;153(2):368-375. doi: 10.1016/j.ygyno.2019.02.002. Epub 2019 Feb 19.
10
Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
Gynecol Oncol. 2006 Sep;102(3):513-6. doi: 10.1016/j.ygyno.2006.01.010. Epub 2006 Feb 28.

引用本文的文献

3
Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization.
Int Cancer Conf J. 2022 Aug 1;11(4):275-279. doi: 10.1007/s13691-022-00560-z. eCollection 2022 Oct.
4
Different uses of the breast implant to prevent empty pelvic complications following pelvic exenteration.
BMJ Case Rep. 2022 Mar 29;15(3):e245630. doi: 10.1136/bcr-2021-245630.
5
Clinical features and outcomes in spontaneous intramural small bowel hematoma: Cohort study and literature review.
Intest Res. 2019 Jan;17(1):135-143. doi: 10.5217/ir.2018.00085. Epub 2018 Oct 10.

本文引用的文献

2
Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Eur J Surg Oncol. 2016 Jun;42(6):823-8. doi: 10.1016/j.ejso.2016.02.016. Epub 2016 Feb 24.
3
Surgical site infection impact of pelvic exenteration procedure.
J Surg Oncol. 2015 Oct;112(5):533-7. doi: 10.1002/jso.24023. Epub 2015 Aug 27.
4
Survival after pelvic exenteration for T4 rectal cancer.
Br J Surg. 2015 Jan;102(1):125-31. doi: 10.1002/bjs.9683.
6
Pelvic exenteration: impact of age on surgical and oncologic outcomes.
Gynecol Oncol. 2014 Jan;132(1):114-8. doi: 10.1016/j.ygyno.2013.11.014. Epub 2013 Nov 18.
7
Pelvic exenteration for the treatment of locally advanced colorectal and bladder malignancies in the modern era.
J Gastrointest Surg. 2014 Apr;18(4):782-8. doi: 10.1007/s11605-013-2400-5. Epub 2013 Nov 8.
8
Clinical algorithms for the diagnosis and management of urological leaks following pelvic exenteration.
Eur J Surg Oncol. 2014 Jun;40(6):775-81. doi: 10.1016/j.ejso.2013.09.024. Epub 2013 Oct 18.
9
Treatment options in recurrent cervical cancer (Review).
Oncol Lett. 2010 Jan;1(1):3-11. doi: 10.3892/ol_00000001. Epub 2010 Jan 1.
10
Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
Eur J Surg Oncol. 2012 Apr;38(4):361-6. doi: 10.1016/j.ejso.2011.12.002. Epub 2012 Jan 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验